The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
This study examined the association between the sequence variation/expression of CX3CR1 , a chemokine receptor, and age‐related macular degeneration (AMD). Peripheral blood from 85 AMD patients and 105 subjects without AMD (controls), as well as ocular tissue from 40 pathological sections with AMD and two normal eye sections, were screened for V249I and T280M, two single nucleotide polymorphisms (SNPs) in CX3CR1 . An increased prevalence, with the highest odds ratio of 3.57, of the I249 and M280 carriers was found among the AMD cases as compared with the controls. When comparing CX3CR1 expression in the archived eye sections, CX3CR1 transcripts were not detectable in the maculae of AMD eyes bearing T/M280; however, transcripts were detected in the maculae of normal eyes bearing T/T280 or T/M280 as well as in the AMD maculae bearing T/T280. Furthermore, lower CX3CR1 protein expression was observed in the maculae of AMD eyes bearing T/M280 compared with the controls bearing T/T280. The I249 and M280 alleles result in a lowered number of receptor binding sites and a decreased ligand affinity. Our data suggest that a decrease, caused by sequence variation and/or lower CX3CR1 expression, in CX3CR1‐induced cellular activities could contribute to AMD development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic variants in CX3CR1, which result in defective CX3CL1-CX3CR1 interactions, have been associated with age-related macular degeneration, a neuroinflammatory disorder.17,18”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [17]
In the citing paper
“the V249I and T280M polymorphisms in CX3CR1 are associated with altered risk for age-related macular degeneration in humans.17,18”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [17]
In the citing paper
“We have reported that the V249I (valine to isoleucine at amino acid 249) and T280M (threonine to methionine at amino acid 280) CX3CR1 SNPs confer increased risk of AMD (Tuo et al., 2004). The OR (CI) of these two SNPs were 1.86 (1.04–3.31) for V249I and 1.94 (1.02–3.69) for T280M.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Tuo et al., 2004
In the citing paper
“which suggested that CX3CR1-mediated decreases in inflammatory cell chemokinesis might contribute to age-related changes in the macula (Chan et al., 2005; Tuo et al., 2004)”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Tuo et al., 2004
In the citing paper
“As described above, the CX3CR1 chemokine receptor found on microglia has been shown to harbor SNPs (T280M and V249I) that have been associated with increased risk of AMD in some reports (Chan et al., 2005; Tuo et al., 2004).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Tuo et al., 2004
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods.
Aickin, M., & Gensler, H. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.726 · Cited by 1,346
Statistics Notes: The odds ratio
Bland, J. M. (2000) · BMJ · doi:10.1136/bmj.320.7247.1468 · Cited by 1,294
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Risk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071 · cited 1×
“As the average life span of humans continues to increase, particularly in the developed countries, the in cidence of AMD is expected to nearly double within the next 25 years (6).”
BackgroundAge-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1413 · Cited by 679
Risk factors associated with age-related macular degeneration
(2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00409-7 · Cited by 633
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631
Age-Related Macular Degeneration
Fine, S. L., Berger, J. W., Maguire, M. G., & Ho, A. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420707 · Cited by 418
Dietary fat and risk for advanced age-related macular degeneration
Seddon, J. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1191 · Cited by 408
Espinosa-Heidmann, D. G., Suner, I. J., Hernandez, E. P., Monroy, D., Csaky, K. G., & Cousins, S. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0038 · Cited by 401
Self-citationPolymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
Moatti, D. (2001) · Blood · doi:10.1182/blood.v97.7.1925 · Cited by 349
Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B., ALT, F., Groups, I. S., Delfraissy, J.-F., Group, S. S., et al. (2000) · Science · doi:10.1126/science.287.5461.2274 · Cited by 323
Genetic Risk of Age-related Maculopathy: Population-Based Familial Aggregation Study
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.12.1646 · Cited by 323
Age‐related Macular Degeneration (AMD)
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_5059 · Cited by 314
Racial differences in the prevalence of age-related macular degeneration
Friedman, D. S., Katz, J., Bressler, N. M., Rahmani, B., & Tielsch, J. M. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90267-1 · Cited by 304 · cited 1×
“It is reported that AMD is more common in Caucasians than in other races that may have more pigment (7, 13).”
BackgroundCombadiere, C., Salzwedel, K., Smith, E. D., Tiffany, H. L., Berger, E. A., & Murphy, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23799 · Cited by 284
McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W. F., D’Agostino, R. B., O’Donnell, C. J., Patel, D. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16790 · Cited by 281
Do age-related macular degeneration and cardiovascular disease share common antecedents?
Snow, K. K., & Seddon, J. M. (1999) · Ophthalmic Epidemiology · doi:10.1076/opep.6.2.125.1558 · Cited by 274
McDermott, D. H., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Merrell, M. N., Epstein, N., Quyyumi, A. A., & Murphy, P. M. (2001) · Circulation Research · doi:10.1161/hh1701.095642 · Cited by 256
Anderson, D. H., Ozaki, S., Nealon, M., Neitz, J., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00961-2 · Cited by 255
Delcourt, C., Michel, F., Colvez, A., Lacroux, A., Delage, M., & Vernet, M.-H. (2001) · Ophthalmic Epidemiology · doi:10.1076/opep.8.4.237.1613 · Cited by 241 · cited 1×
“Although several pathological features are shared between AMD drusen and arteriosclerosis plaques, th e findings of epidemiological studies on the association between AMD and hypertensi o remain controversial (10, 35, 36).”
BackgroundChanges in choriocapillaris and retinal pigment epithelium in age-related macular degeneration.
Lutty, G. A., Grunwald, J., Majji, A. B., Uyama, M., & Yoneya, S. (1999) · PubMed · Cited by 223
A Twin Study of Age-related Macular Degeneration
MEYERS, S. M., GREENE, T., & GUTMAN, F. A. (1995) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)72729-1 · Cited by 215
Age-related macular degeneration–a genome scan in extended families
Majewski, J., Schultz, D. W., Weleber, R. G., Schain, M. B., Edwards, A. O., Matise, T. C., Acott, T. S., Ott, J., & Klein, M. L. (2003) · The American Journal of Human Genetics · doi:10.1086/377701 · Cited by 201
Veränderungen der Erfahrungs- und Handlungsräume des Kindes durch audiovisuelle Medien
Lukesch, H. (1995) · University of Regensburg Publication Server (University of Regensburg) · Cited by 178
Risk factors for age-related macular degeneration: an update
Hyman, L., & Neborsky, R. (2002) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200206000-00007 · Cited by 163
Foxman, E. F., Zhang, M., Hurst, S. D., Muchamuel, T., Shen, D., Wawrousek, E. F., Chan, C.-C., & Gery, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2483 · Cited by 148
Self-citationAge-Related Macular Degeneration: Epidemiology and Optimal Treatment
la Cour, M., Kiilgaard, J. F., & Nissen, M. H. (2002) · Drugs & Aging · doi:10.2165/00002512-200219020-00003 · Cited by 130
Schick, J. H., Iyengar, S. K., Klein, B. E. K., Klein, R., Reading, K., Liptak, R., Millard, C., Lee, K. E., Tomany, S. C., Moore, E., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375500 · Cited by 117
Schmidt, S., Saunders, A. M., Paz, L. P. M. D. L., Postel, E. A., Heinis, R. M., Agarwal, A., Scott, W. K., Gilbert, J. R., McDowell, J., Bazyk, A., et al. (2000) · PubMed · Cited by 115
Genetic factors of age-related macular degeneration
Tuo, J., Bojanowski, C. M., & Chan, C. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.02.001 · Cited by 109
Self-citationSilverman, M. D., Zamora, D. O., Pan, Y., Texeira, P. V., Baek, S.-H., Planck, S. R., & Rosenbaum, J. T. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0233 · Cited by 99
Liesegang, T. J. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01493-9 · Cited by 94
Genetic Polymorphism in CX 3 CR1 and Risk of HIV Disease
McDermott, D. H., Colla, J. S., Kleeberger, C. A., Plankey, M. W., Rosenberg, P. S., Smith, E. D., Zimmerman, P. A., Combadière, C., Leitman, S. F., Kaslow, R. A., et al. (2000) · Science · doi:10.1126/science.290.5499.2031a · Cited by 89
Age related macular degeneration in monozygotic twins and their spouses in Iceland
Gottfredsdottir, M. S., Sverrisson, T., Musch, D. C., & Stefánsson, E. (1999) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.1999.770413.x · Cited by 72
Mechanism of age related macular degeneration
Husain, D., Ambati, B. K., ADAMIS, A., & Miller, J. W. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(01)00009-8 · Cited by 61
Familial Aggregation of Age-related Maculopathy
de Jong, P. T. V. M., Klaver, C. C. W., Wolfs, R. C. W., Assink, J. J. M., & Hofman, A. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71715-5 · Cited by 46
Sunnemark, D., Eltayeb, S., Wallström, E., Appelsved, L., Malmberg, Å., Lassmann, H., Ericsson‐Dahlstrand, A., Piehl, F., & Olsson, T. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00490.x · Cited by 45
Genomic Organization and Evolution of the CX3CR1/CCR8 Chemokine Receptor Locus
DeVries, M. E., Cao, H., Wang, J., Xu, L., Kelvin, A. A., Ran, L., Chau, L. A., Madrenas, J., Hegele, R. A., & Kelvin, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211422200 · Cited by 33
Cited by
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
“Age, race, self-conditions such as basic diseases (diabetes, hypertension, etc.), and complement system activation play important roles in the incidence of AMD.”
BackgroundInfluentialBachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
“The first evidence in humans that chemokines have a genetic role in age-related macular degeneration (AMD) involved CX3CR1 (Tuo et al., 2004).”
Combadière, C., Feumi, C., Raoul, W., Keller, N., Rodéro, M., Pézard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31692 · Cited by 618
“Journal of Clinical Investigation, American Society for Clinical Investigation, 2007, 117 (10), pp.”
BackgroundResultInfluentialCX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., Weeber, E. J., Bickford, P. C., & Gemma, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-11.2011 · Cited by 624
“These polymorphisms are associated with the neuroinflammatory disorder human age-related macular degeneration (Tuo et al., 2004; Chan et al., 2005).”
BackgroundMolecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582
“As described above, the CX3CR1 chemokine receptor found on microglia has been shown to harbor SNPs (T280M and V249I) that have been associated with increased risk of AMD in some reports (Chan et al., 2005; Tuo et al., 2004).”
BackgroundSelf-citation
Metadata
- Authors
- Tuo, J., Smith, B. C., Bojanowski, C. M., Meleth, A. D., Gery, I., Csaky, K. G., Chew, E. Y., & Chan, C.-C.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-06-18
- Volume
- 18
- Issue
- 11
- Pages
- 1297-1299
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC1971128
- OpenAlex
- W2097452332
- Cited by
- 215
- References
- 43
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 10 · 2017: 10 · 2016: 7 · 2015: 13 · 2014: 11 · 2013: 18 · 2012: 21
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health (Z99 EY999999)
- National Eye Institute (Z01EY000222, Z01EY000418)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- age-related macular degeneration, CX3CR1, chemokine receptors, single nucleotide polymorphisms, gene expression, macula, genetic susceptibility, receptor binding sites, ligand binding affinity
- MeSH terms
- CX3C Chemokine Receptor 1, Aged, Aging, Blood Donors, Chemotaxis, Eye Proteins, Female, Gene Expression Regulation, Gene Frequency, Genetic Testing, Heterozygote, Humans, Macular Degeneration, Male, Membrane Proteins, Middle Aged, Polymorphism, Restriction Fragment Length, Risk Factors, RNA, Messenger, Odds Ratio, Case-Control Studies, Receptors, Chemokine, Amino Acid Substitution, Genetic Predisposition to Disease, Mutation, Missense, Polymorphism, Single Nucleotide, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.